Cost for QD employees to rent an apartment in Chico, CA. $1,200/month. Please turn off your ad blocker in Quality Digest
Our landlords thank you.
Research and Markets
Published: Tuesday, April 22, 2008 - 22:00 (Research and Markets: Dublin, Ireland) – A Frost & Sullivan research service titled “Automation and Control Solutions in the European Pharmaceutical Market” provides an analysis of the various factors driving and restraining the market, revenue forecasts, geographic trends and competitive structure. In this research, Frost & Sullivan’s expert analysts thoroughly examine the following markets: programmable logic controllers (PLC), distributed control systems, supervisory control and data acquisition (SCADA), manufacturing execution systems (MES), human machine interface (HMI), and advanced process control in the European region. The process analytical technology (PAT) initiative arose from a need felt by the pharmaceutical industry to lower production costs due to pricing pressures. Traditionally, a production process was followed, wherein the quality of the manufactured drug was checked at the end of the process. However, with the PAT initiative, pharmaceutical companies have been able to ensure the quality of their drugs during the production process itself, supporting reduced time to market, reduced costs, and improved quality of products. These two factors are driving growth in the automation and control solutions market due to the scope they present for the use of automation systems such as electronic batch recording systems and analytical equipment, as well as solutions for improving visibility through the production process. Along with PAT, the MES segment is one of the fastest growing product segments within the automation and control solutions market. MES, which acts as a bridge between the shop-floor automation layer such as PLCs, SCADA/HMI systems and the enterprise level solutions such as enterprise resource planning systems, provides the required visibility through the pharmaceutical production process. MES’s percent share in the overall automation and control solutions in the European pharmaceutical market is expected to be in the range of 20 to 25 percent in 2013. For more information, visit www.researchandmarkets.com/reports/c88688. Quality Digest does not charge readers for its content. We believe that industry news is important for you to do your job, and Quality Digest supports businesses of all types. However, someone has to pay for this content. And that’s where advertising comes in. Most people consider ads a nuisance, but they do serve a useful function besides allowing media companies to stay afloat. They keep you aware of new products and services relevant to your industry. All ads in Quality Digest apply directly to products and services that most of our readers need. You won’t see automobile or health supplement ads. So please consider turning off your ad blocker for our site. Thanks,Compliance to Regulations, PAT Initiative Remain Top Market Drivers in European Market
Our PROMISE: Quality Digest only displays static ads that never overlay or cover up content. They never get in your way. They are there for you to read, or not.
Quality Digest Discuss
About The Author
Research and Markets
© 2022 Quality Digest. Copyright on content held by Quality Digest or by individual authors. Contact Quality Digest for reprint information.
“Quality Digest" is a trademark owned by Quality Circle Institute, Inc.